Welcome to the HOPE for Harvey Foundation for DLG4
Helping Overcome PSD-95 Errors for the DLG4 Community
Welcome to the HOPE for Harvey Foundation for DLG4
Helping Overcome PSD-95 Errors for the DLG4 Community
Helping Overcome PSD-95 Errors for the DLG4 Community
Helping Overcome PSD-95 Errors for the DLG4 Community
To further research and create translational medicine and treatment options that create a better quality of life for DLG4 patients.
In the long-term we hope our efforts will go beyond DLG4 and help increase research and legislation in this field for early detection and treatment of all rare genetic disorders.
Americans affected by rare genetic diseases like DLG4
identified
genetic disorders
of disorders have an FDA-approved treatment
In March of 2020, we gave birth to our second child, Harvey. At 18-months, he was diagnosed with DLG4-related Synaptopathy. Harvey is now 4-years-old, and struggles with seizures, independent mobility and cannot speak or feed himself. He has difficulty learning due to a random, letter mutation on the DLG4 gene
August 2025, we just started working on a new mRNA treatment approach for DLG4! Grann Pharmaceuticals just successfully entered clinical trials in another rare disease in record-breaking time.
Help make that possible for Harvey and DLG4!
There's still hope. Donate today!
100% of donations go straight to researchers
Powered by
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.